Drug profile · INN
pravastatin sodium
PRAVASTATIN SODIUM
pravastatin sodium (PRAVASTATIN SODIUM) is a hmg-coa reductase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — pravastatin sodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 3
- Programs
- 4
- Data quality
- 0.84
Quick answer
pravastatin sodium (PRAVASTATIN SODIUM) is a hmg-coa reductase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
HMG-CoA reductase inhibitor
Primary target: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is pravastatin sodium?
pravastatin sodium (PRAVASTATIN SODIUM) is a hmg-coa reductase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pravastatin sodium?
PRAVASTATIN SODIUM is a marketed brand name for pravastatin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pravastatin sodium?
pravastatin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.